|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined With radiotherapy: schedule - dependent enhancement of antitumor activity 显示文摘 | Williams K J Telfer B A Brave S | 2004 | Clinical Cancer Research2004，10，24： | 1 |
| 2 | FDA review summary:mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation显示文摘 | Brave M Farrell A Ching Lin S | | 0，，： | 1 |
| 3 | Murine models for HIV vaccination and challenge 显示文摘 | Boberg A Brave A Johansson S | 2008 | Expert Rev Vaccines2008，7，1： | 1 |
| 4 | Synthesis and characterization of indium oxide nanoparticles显示文摘 | Mulali A Brave A Leppert V J | 2001 | Nano Lett2001，1，6： | 1 |
| 5 | Diagnosing the financial system: Financial conditions and financial stress 显示文摘 | Brave S Butters R A | 2012 | Internation- al Joui''nal of Central Banking2012，8，2： | 1 |
| 6 | Progress towards de- velopment of an HIV vaccine: report of the AIDS Vaccine 2009 Conference 显示文摘 | ROSS AL BRAVE A SCARLATTI G | 2010 | The Lancet Infectious Diseases2010，10，5： | 1 |
| 7 | Monitoring financial stability: A financial conditions index approach 显示文摘 | Brave S Butters R A | 2011 | Economic Perspectives2011，，35： | 1 |
| 8 | Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen显示文摘 | BRAVE A HALLENGARD D GUDMUNDSDOTTER L | 2009 | Vaccine2009，27，28： | 1 |
| 9 | ZD6474, a potent inhibitor of vascular endothelial growfll factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity显示文摘 | Williams K J Teller B A Brave S | 2004 | Clin Cancer Res2004，10，24： | 1 |
| 10 | Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer 显示文摘 | Hallermalm K Johansson S Brave A | 2007 | Scand J Immunol2007，66，1： | 1 |
| 11 | Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus(HIV)DNA显示文摘 | Zuber AK Brave A Engstrom G | 2004 | Vaccine2004，22，6： | 1 |
| 12 | Topotecan in combination with cisplatin for the treatment of stage IVB,recurrent,or persistent cervi- ca1 eaneer显示文摘 | Brave M Dagher R Farrell A | 2006 | Oneology (Wilhston Park)2006，20，11： | 1 |
| 13 | Topoteean in eombination with cisplatin for tre atment of stage IVb,recurrent,or persistent cervical cancer显示文摘 | Brave M Daghr R Farrell A | 2006 | Oncology2006，20，14： | 1 |
| 14 | Intranasal immunization of young mice with a multigene HIV-I vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses 显示文摘 | Brave A Hallengard D Schroder U | 2008 | Vaccine2008，26，40： | 1 |
| 15 | Monitoring financial stability: A finan- cial conditions index approach显示文摘 | Brave S Butters R A | 2011 | Federal Reserve Bank of Chi- cago Economic Perspectives Q2011，，1： | 1 |
| 16 | ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: Schedule dependent enhancement of antitumor activity显示文摘 | Williams K J Teffer B A Brave S | 2004 | Clin Cancer Res2004，10，： | 1 |
| 17 | What Decusion Neuroscince Teaches Financial Decision Making显示文摘 | Brave A J B Heaton | 2004 | Annum Review of Financial Economics2004，，1： | 1 |
| 18 | Synthesis and characterization of indium oxide nanoparticles显示文摘 | Mulali A Brave A Leppert V J etal | 2001 | Nano Lett2001，1，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员